---
title: "Adrabetadex (Lembaz) in Infantile-onset Niemann-Pick disease type C: Dosage forms and strengths"
description: "Formulary evidence on Adrabetadex (Lembaz, VTS-270) in Infantile-onset Niemann-Pick disease type C: Dosage forms and strengths. Topics: Injection: strength and appearance; Composition, inactive ingredients, and pH; Package and national drug code; Storage of the vial; 1 further topic. 5 evidence topics quoted from 2 sources."
canonical: "https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/product-information-and-disease-description/dosage-forms-and-strengths"
published: "2026-11-19T12:08:36-05:00"
modified: "2026-11-19T12:08:36-05:00"
---

# Adrabetadex (Lembaz) in Infantile-onset Niemann-Pick disease type C: Dosage forms and strengths

<a id="heading-2.1.2.2"></a>

## 2.1.2.2 Dosage Forms and Strengths

<a id="topic-2.1.2.2-1"></a>

### Injection: strength and appearance

> “Injection: 900 mg/4.5 mL (200 mg/mL) of adrabetadex as a sterile, clear, colorless solution in a single-dose vial.”
> “LEMBAZ (adrabetadex) injection is supplied as a clear, colorless, preservative-free, sterile solution in a single-dose vial for intrathecal use.”

Source: [Lembaz prescribing information (2026)](https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/220996s000lbl.pdf)

<a id="topic-2.1.2.2-2"></a>

### Composition, inactive ingredients, and pH

> “Each 1 mL contains 200 mg of adrabetadex and inactive ingredients sodium chloride USP (2 mg) and Water for Injection USP.”
> “The pH is adjusted with hydrochloric acid and sodium hydroxide as needed. The pH is 6.0 to 8.0.”
> “The empirical formula is (C6H10O5)7(C3H6O)n, where n=4.1 to 4.8, and the average molecular weight is approximately 1,371 to 1,432 g/mol.”

Source: [Lembaz prescribing information (2026)](https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/220996s000lbl.pdf)

<a id="topic-2.1.2.2-3"></a>

### Package and national drug code

| Package | NDC number | Strength | Contents |
| --- | --- | --- | --- |
| Carton | “Carton: 87230-101-01” | “900 mg/4.5 mL” | “One single-dose vial in a carton” |
| Vial | “Vial: 87230-101-02” | “900 mg/4.5 mL” | “One single-dose vial in a carton” |

Source: [Lembaz prescribing information (2026)](https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/220996s000lbl.pdf)

<a id="topic-2.1.2.2-4"></a>

### Storage of the vial

> “Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30ºC (59°F to 86ºF) [see USP Controlled Room Temperature].”
> “Do not refrigerate. Do not freeze.”

Source: [Lembaz prescribing information (2026)](https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/220996s000lbl.pdf)

<a id="topic-2.1.2.2-5"></a>

### Expiry dating period

> “Based on the stability data submitted to date, the expiry dating period for Lembaz (adrabetadex) injection shall be 36 months from the date of manufacture when stored at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30ºC (59°F to 86ºF) [see USP Controlled Room Temperature].”

Source: [FDA NDA 220996 approval letter (2026)](https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/220996Orig1s000ltr.pdf)

<a id="topic-2.1.2.2-6"></a>

### Material safety data sheet

No evidence found.

## Related pages
- [Adrabetadex (Lembaz): Infantile-onset Niemann-Pick disease type C](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c) · [Markdown](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c.md)
- [Adrabetadex (Lembaz) in Infantile-onset Niemann-Pick disease type C: Terms and abbreviations](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/terms-and-abbreviations) · [Markdown](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/terms-and-abbreviations.md)
- [Adrabetadex (Lembaz): Infantile-onset Niemann-Pick disease type C](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/executive-summary) · [Markdown](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/executive-summary.md)
- [Adrabetadex (Lembaz) in Infantile-onset Niemann-Pick disease type C: Product information and disease description](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/product-information-and-disease-description) · [Markdown](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/product-information-and-disease-description.md)
- [Adrabetadex (Lembaz) in Infantile-onset Niemann-Pick disease type C: Clinical evidence](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/clinical-evidence) · [Markdown](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/clinical-evidence.md)
- [Adrabetadex (Lembaz) in Infantile-onset Niemann-Pick disease type C: Economic information and modeling report](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/economics) · [Markdown](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/economics.md)
- [Adrabetadex (Lembaz) in Infantile-onset Niemann-Pick disease type C: References](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/references) · [Markdown](https://www.evicenter.com/drugs/adrabetadex--infantile-onset-niemann-pick-disease-type-c/references.md)
